OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001610820

BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Corp. (CIK 0001610820, ticker BCTX) reported net income of -$26.31 million (-$26,311,867) for FY2025 (2024-08-01 to 2025-07-31) and total assets of $21.65 million ($21,649,706) for FY2025 (as of 2025-07-31), as filed in its 10-K filed 2025-10-16 (accession 0001493152-25-018212).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends July 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001610820
TickersBCTX (Nasdaq), BCTXL (Nasdaq), BCTXZ (Nasdaq)
EINnot in EDGAR (or not a valid EIN)
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationA1
Fiscal year endJuly 31
Filer category<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_5egqdrw45ngtm1kxmxagqhfz35
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$26,311,867FY20252024-08-01 to 2025-07-3110-K2025-10-160001493152-25-018212NetIncomeLoss
Total assets$21,649,706FY2025as of 2025-07-3110-K2025-10-160001493152-25-018212Assets
Stockholders' equity$17,334,046FY2025as of 2025-07-3110-K2025-10-160001493152-25-018212StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Operating cash flow-$28,170,520FY20252024-08-01 to 2025-07-3110-K2025-10-160001493152-25-018212NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$62.19 per shareFY20252024-08-01 to 2025-07-3110-K2025-10-160001493152-25-018212EarningsPerShareDiluted
Shares outstanding1,883,906 sharesFY2025as of 2025-10-1510-K2025-10-160001493152-25-018212EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20252024-08-01 to 2025-07-31-$26,311,86710-K2025-10-160001493152-25-018212
Net incomeFY20242023-08-01 to 2024-07-31-$4,791,46610-K2025-10-160001493152-25-018212
Net incomeFY20232022-08-01 to 2023-07-31-$20,302,39410-K2024-10-290001493152-24-042743
Net incomeFY20222021-08-01 to 2022-07-31-$26,838,90310-K2023-10-250001493152-23-038298

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-06-092026-04-300001493152-26-027928form10-q.htm
10-Q2026-03-102026-01-310001493152-26-009557form10-q.htm
10-Q2025-12-112025-10-310001493152-25-027240form10-q.htm
10-K2025-10-162025-07-310001493152-25-018212form10-k.htm
10-Q2025-06-162025-04-300001641172-25-015265form10-q.htm
10-Q2025-03-122025-01-310001493152-25-010052form10-q.htm
10-Q2024-12-162024-10-310001493152-24-050214form10-q.htm
10-K2024-10-292024-07-310001493152-24-042743form10-k.htm
10-Q2024-06-142024-04-300001493152-24-023867form10-q.htm
10-Q2024-03-182024-01-310001493152-24-010354form10-q.htm
10-Q2023-12-142023-10-310001493152-23-044892form10-q.htm
10-K2023-10-252023-07-310001493152-23-038298form10-k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001610820published by the sourcedata.sec.gov/submissions/CIK0001610820.json2026-10-21

Former names

NameFromTo
Ansell Capital Corp.2014-06-202014-06-20

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001610820.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001610820.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001610820" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001610820/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001610820/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1610820"}

On SEC EDGAR

About this data